Your browser doesn't support javascript.
loading
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer.
Alaimo, Alessandro; Genovesi, Sacha; Annesi, Nicole; De Felice, Dario; Subedi, Saurav; Macchia, Alice; La Manna, Federico; Ciani, Yari; Vannuccini, Federico; Mugoni, Vera; Notarangelo, Michela; Libergoli, Michela; Broso, Francesca; Taulli, Riccardo; Ala, Ugo; Savino, Aurora; Cortese, Martina; Mirzaaghaei, Somayeh; Poli, Valeria; Bonapace, Ian Marc; Papotti, Mauro Giulio; Molinaro, Luca; Doglioni, Claudio; Caffo, Orazio; Anesi, Adriano; Nagler, Michael; Bertalot, Giovanni; Carbone, Francesco Giuseppe; Barbareschi, Mattia; Basso, Umberto; Dassi, Erik; Pizzato, Massimo; Romanel, Alessandro; Demichelis, Francesca; Kruithof-de Julio, Marianna; Lunardi, Andrea.
Afiliação
  • Alaimo A; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy. alessandro.alaimo@unitn.it.
  • Genovesi S; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Annesi N; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • De Felice D; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Subedi S; Department for BioMedical Research, Urology Research Laboratory, University of Bern, Bern, Switzerland.
  • Macchia A; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • La Manna F; Department for BioMedical Research, Urology Research Laboratory, University of Bern, Bern, Switzerland.
  • Ciani Y; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Vannuccini F; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Mugoni V; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Notarangelo M; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Libergoli M; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Broso F; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Taulli R; Department of Oncology, University of Torino, Torino, Italy.
  • Ala U; Center for Experimental Research and Medical Studies (CeRMS), AOU Città della Salute e della Scienza di Torino, Torino, Italy.
  • Savino A; Department of Veterinary Sciences, University of Torino, Torino, Italy.
  • Cortese M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Mirzaaghaei S; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Poli V; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Bonapace IM; Molecular Biotechnology Center (MBC) "Guido Tarone", University of Torino, Torino, Italy.
  • Papotti MG; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Molinaro L; Molecular Biotechnology Center (MBC) "Guido Tarone", University of Torino, Torino, Italy.
  • Doglioni C; Department of Biotechnology and Life Sciences, University of Insubria, Busto Arsizio, VA, Italy.
  • Caffo O; Department of Pathology, University of Torino and AOU Città della Salute e della Scienza di Torino, Torino, Italy.
  • Anesi A; Department of Pathology, University of Torino and AOU Città della Salute e della Scienza di Torino, Torino, Italy.
  • Nagler M; Division of Pathology, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute IRCCS Vita Salute, San Raffaele University, Milano, Italy.
  • Bertalot G; Medical Oncology Department, Santa Chiara Hospital-APSS, Trento, Italy.
  • Carbone FG; Operative Unit of Clinical Pathology, Santa Chiara Hospital-APSS, Trento, Italy.
  • Barbareschi M; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Basso U; Operative Unit of Anatomy Pathology, Santa Chiara Hospital-APSS, Trento, Italy.
  • Dassi E; Centre for Medical Sciences-CISMed, University of Trento, Trento, Italy.
  • Pizzato M; Operative Unit of Anatomy Pathology, Santa Chiara Hospital-APSS, Trento, Italy.
  • Romanel A; Operative Unit of Anatomy Pathology, Santa Chiara Hospital-APSS, Trento, Italy.
  • Demichelis F; Centre for Medical Sciences-CISMed, University of Trento, Trento, Italy.
  • Kruithof-de Julio M; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • Lunardi A; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
EMBO J ; 43(5): 780-805, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38316991
ABSTRACT
Inflammation is a common condition of prostate tissue, whose impact on carcinogenesis is highly debated. Microbial colonization is a well-documented cause of a small percentage of prostatitis cases, but it remains unclear what underlies the majority of sterile inflammation reported. Here, androgen- independent fluctuations of PSA expression in prostate cells have lead us to identify a prominent function of the Transient Receptor Potential Cation Channel Subfamily M Member 8 (TRPM8) gene in sterile inflammation. Prostate cells secret TRPM8 RNA into extracellular vesicles (EVs), which primes TLR3/NF-kB-mediated inflammatory signaling after EV endocytosis by epithelial cancer cells. Furthermore, prostate cancer xenografts expressing a translation-defective form of TRPM8 RNA contain less collagen type I in the extracellular matrix, significantly more infiltrating NK cells, and larger necrotic areas as compared to control xenografts. These findings imply sustained, androgen-independent expression of TRPM8 constitutes as a promoter of anticancer innate immunity, which may constitute a clinically relevant condition affecting prostate cancer prognosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Canais de Cátion TRPM Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Canais de Cátion TRPM Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article